Infliximab

Remsima 40 MG/ML Concentrado Para Solucion Para Perfusion

40 mg/ml concentrado para solución para perfusiónSpainMarketedAuthorised 13 Apr 2026

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Infliximab

Remsima 40 MG/ML Concentrado Para Solucion Para Perfusion

40 mg/ml concentrado para solución para perfusiónSpainMarketedAuthorised 13 Apr 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Remsima 100 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Celltrion Healthcare Hungary Kft.

Remsima 120 mg/ml oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.

Remsima 120 mg/ml oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Celltrion Healthcare Hungary Kft.

REMSIMA 100mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Celltrion Healthcare Hungary KFT.

Remsima®Serbia · 120mg · rastvor za injekciju u napunjenom injekcionom penu · Oktal Pharma DOO Beograd

REMSIMA 100 mg powder for solution for infusionSaudi Arabia · Celltrion INC

Remsima SC Auto injector Pre-filled penSaudi Arabia · Vetter Pharma-Fertigung GMBH & Co. KG

Remsima SCSaudi Arabia · Vetter Pharma-Fertigung GmbH & Co.KG

Remsima Solution for Subcutaneous Injection 120 MG/ML in Pre-Filled PenSingapore · 120mg/ml · injection, solution · Celltrion Healthcare Singapore Private Limited

Remsima Solution for Subcutaneous Injection 120 MG/ML in Pre-Filled SyringeSingapore · 120mg/ml · injection, solution · Celltrion Healthcare Singapore Private Limited

Remsima® Powder for Concentrate for Solution for Infusion 100 MG/VialSingapore · 100mg/vial · injection, powder, lyophilized, for suspension · Celltrion Healthcare Singapore Private Limited

ZymfentraUnited States · 120MG/ML · Injection · CELLTRION, Inc.

ZymfentraUnited States · 120MG/ML · injectable · Celltrion

FlixabiItaly · Polvere per concentrato per soluzione per infusione · Samsung Bioepis NL B.V.

RemicadeItaly · Polvere per concentrato per soluzione per infusione · Janssen-Cilag International N.V.

RemicadeNew Zealand · Inj 100 mg

InflectraUnited States · 100MG · injectable · Celltrion INC

AvsolaBrazil · Amgen Biotecnologia do Brasil Ltda.

Bio Manguinhos InfliximabeBrazil · Fundação Oswaldo Cruz

FlixabiEuropean Union · Samsung Bioepis NL B.V.

InflectraEuropean Union · Pfizer Europe MA EEIG

FlixabiCroatia

RemicadeCroatia

INFLECTRA 100 mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Pfizer Europe Ma Eeig

INFLECTRA 100mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Hospira UK Limited

Ixifi powder for concentrate for solution for infusionTaiwan · 凍晶注射劑 · 美商惠氏藥廠（亞洲）股份有限公司台灣分公司

Packs

Pack	Code	Status
REMSIMA 40 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 2,5 ml	770273
REMSIMA 40 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8,75 ml	770274

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Infliximab
Strength: 40 mg/ml
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 13 Apr 2026
Registration: 113853018
Marketing authorisation holder: Celltrion Healthcare Hungary Kft.
Procedure: EU centralised
Supply: Uso Hospitalario

Spain

Remsima 100 MG Polvo Para Concentrado Para Solucion Para PerfusionInfliximab · 100 mg · polvo para concentrado para solución para perfusiónSpain

Remsima 120 MG Solucion Inyectable en Pluma PrecargadaInfliximab · 120 mg/ml · solución inyectable en pluma precargadaSpain

Zessly 100 MG Polvo Para Concentrado Para Solucion Para PerfusionInfliximab · 100 mg · polvo para concentrado para solución para perfusiónSpain

Remsima 100 MG Polvo Para Concentrado Para Solucion Para PerfusionInfliximab · 100 mg · polvo para concentrado para solución para perfusiónSpain

Remsima 120 MG Solucion Inyectable en Jeringa PrecargadaInfliximab · 120 mg/ml · solución inyectable en jeringa precargadaSpain

Inflectra 100 MG Polvo Para Concentrado Para Solucion Para PerfusionInfliximab · 100 mg · polvo para concentrado para solución para perfusiónSpainWithdrawn